CRISPR-Mediated Gene Correction in a Severe Humanized Mouse Model of Duchenne Muscular Dystrophy
Publication
, Conference
Bulaklak, K; Bohning, J; Gough, V; Daniels, H; McCall, A; ElMallah, M; Gersbach, CA
Published in: MOLECULAR THERAPY
2020
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2020
Volume
28
Issue
4
Start / End Page
218 / 219
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bulaklak, K., Bohning, J., Gough, V., Daniels, H., McCall, A., ElMallah, M., & Gersbach, C. A. (2020). CRISPR-Mediated Gene Correction in a Severe Humanized Mouse Model of Duchenne Muscular Dystrophy. In MOLECULAR THERAPY (Vol. 28, pp. 218–219).
Bulaklak, Karen, Joel Bohning, Veronica Gough, Heather Daniels, Angela McCall, Mai ElMallah, and Charles A. Gersbach. “CRISPR-Mediated Gene Correction in a Severe Humanized Mouse Model of Duchenne Muscular Dystrophy.” In MOLECULAR THERAPY, 28:218–19, 2020.
Bulaklak K, Bohning J, Gough V, Daniels H, McCall A, ElMallah M, et al. CRISPR-Mediated Gene Correction in a Severe Humanized Mouse Model of Duchenne Muscular Dystrophy. In: MOLECULAR THERAPY. 2020. p. 218–9.
Bulaklak, Karen, et al. “CRISPR-Mediated Gene Correction in a Severe Humanized Mouse Model of Duchenne Muscular Dystrophy.” MOLECULAR THERAPY, vol. 28, no. 4, 2020, pp. 218–19.
Bulaklak K, Bohning J, Gough V, Daniels H, McCall A, ElMallah M, Gersbach CA. CRISPR-Mediated Gene Correction in a Severe Humanized Mouse Model of Duchenne Muscular Dystrophy. MOLECULAR THERAPY. 2020. p. 218–219.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2020
Volume
28
Issue
4
Start / End Page
218 / 219
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences